Literature DB >> 9736148

Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation.

H Nakagami1, K Yamamoto, U Ikeda, T Mitsuhashi, T Goto, K Shimada.   

Abstract

BACKGROUND: Significant mitral regurgitation (MR) is protective against left atrial (LA) spontaneous echo contrast formation that is associated with an increased thromboembolic risk. However, the effects of MR on the risk of stroke in patients with nonrheumatic atrial fibrillation (AF) have been unknown. We studied whether or not MR was associated with a decreased risk of stroke in patients with nonrheumatic AF.
METHODS: We performed an observational analysis of retrospectively collected data on 290 patients with nonrheumatic AF. Left atrial diameter (LAD) and the degree of MR were estimated by transthoracic echocardiography. Risk factors for stroke were assessed by univariate and multivariate analyses. The mean follow-up was 7.4 years.
RESULTS: Among these patients, 68 had a stroke during the follow-up (rate of stroke per year of follow-up 3.2%). In 95 patients with LAD of > or =48 mm, the incidence of stroke (9%) in the severe MR group (moderate or severe, n=43) was significantly lower than that (25%) of the mild MR group (none, trivial, or mild; n=52) (chi-square=3.95, p=0.047). The relative risk of stroke for increase in MR from mild to severe groups, for every 10 mm increment in LA size, for sex, and for every increase of 10 years of age was 0.45 (95% CI, 0.20 to 0.97), 1.06 (95% CI, 0.75 to 1.49), 0.98 (95% CI, 0.55 to 1.72), and 1.33 (95% CI, 1.04 to 1.71), respectively.
CONCLUSIONS: In patients with nonrheumatic AF, age was an independent predictor of an increased risk of stroke, and MR may be protective against stroke, especially in those patients with LA enlargement.

Entities:  

Mesh:

Year:  1998        PMID: 9736148     DOI: 10.1016/s0002-8703(98)70231-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Bilateral atrial appendage thrombus formation in a patient with atrial fibrillation.

Authors:  Ayano Enzan; Koichiro Imai; Teruyoshi Kume; Tomoko Tamada; Kikuko Obase; Ryotaro Yamada; Yoji Neishi; Shiro Uemura
Journal:  J Echocardiogr       Date:  2015-07-24

Review 2.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

Review 3.  AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Authors:  Nasir Shariff; Abdul Aleem; Mukesh Singh; Yuan Z Li; Stacey J Smith
Journal:  J Atr Fibrillation       Date:  2012-10-06

4.  The risk stratification in atrial fibrillation.

Authors:  Domenico Prisco; Caterina Cenci; Elena Silvestri; Giacomo Emmi; Tommaso Barnini; Carlo Tamburini
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

5.  Black defects in severe spontaneous echo contrast teach us the protective aspect of mitral regurgitation visually.

Authors:  Atsushi Mizuno; Nobuhiro Takao; Koichiro Niwa
Journal:  J Cardiovasc Ultrasound       Date:  2013-03-20

6.  Right atrial spontaneous echo contrast indicates a high incidence of perfusion defects in pulmonary scintigraphy in patients with atrial fibrillation.

Authors:  Yoshinori Yasuoka; Johji Naito; Keiji Hirooka; Wakatomi Chin; Kunio Miyatake; Hideo Kusuoka; Yukihiro Koretsune
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

Review 7.  Percutaneous Left Atrial Appendage Closure: is there a Role in Valvular Atrial Fibrillation.

Authors:  Chetan Huded; Amar Krishnaswamy; Samir Kapadia
Journal:  J Atr Fibrillation       Date:  2017-02-28

8.  Coronary artery disease, left ventricular hypertrophy and diastolic dysfunction are associated with stroke in patients affected by persistent non-valvular atrial fibrillation: a case-control study.

Authors:  Pasquale Palmiero; Maria Maiello; Andrea Passantino
Journal:  Heart Int       Date:  2009-06-30

Review 9.  Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.

Authors:  Luigi Di Biase
Journal:  J Am Heart Assoc       Date:  2016-02-18       Impact factor: 5.501

10.  Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair.

Authors:  Ashwin S Nathan; Lin Yang; Zhi Geng; Elias J Dayoub; Sameed Ahmed M Khatana; Paul N Fiorilli; Howard C Herrmann; Wilson Y Szeto; Pavan Atluri; Michael A Acker; Nimesh D Desai; David S Frankel; Francis E Marchlinski; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld
Journal:  Am Heart J       Date:  2020-10-24       Impact factor: 5.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.